5-45266487-A-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_021072.4(HCN1):​c.1783+602T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.342 in 152,054 control chromosomes in the GnomAD database, including 11,141 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.34 ( 11141 hom., cov: 32)

Consequence

HCN1
NM_021072.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.750

Publications

11 publications found
Variant links:
Genes affected
HCN1 (HGNC:4845): (hyperpolarization activated cyclic nucleotide gated potassium channel 1) The membrane protein encoded by this gene is a hyperpolarization-activated cation channel that contributes to the native pacemaker currents in heart and neurons. The encoded protein can homodimerize or heterodimerize with other pore-forming subunits to form a potassium channel. This channel may act as a receptor for sour tastes. [provided by RefSeq, Oct 2011]
HCN1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 24
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • generalized epilepsy with febrile seizures plus
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • generalized epilepsy with febrile seizures plus, type 10
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 5-45266487-A-G is Benign according to our data. Variant chr5-45266487-A-G is described in ClinVar as Benign. ClinVar VariationId is 3256856.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.452 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021072.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HCN1
NM_021072.4
MANE Select
c.1783+602T>C
intron
N/ANP_066550.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HCN1
ENST00000303230.6
TSL:1 MANE Select
c.1783+602T>C
intron
N/AENSP00000307342.4
HCN1
ENST00000673735.1
c.*8+28T>C
intron
N/AENSP00000501107.1
HCN1
ENST00000637305.1
TSL:5
n.946+602T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.342
AC:
51986
AN:
151936
Hom.:
11142
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0839
Gnomad AMI
AF:
0.569
Gnomad AMR
AF:
0.416
Gnomad ASJ
AF:
0.403
Gnomad EAS
AF:
0.304
Gnomad SAS
AF:
0.201
Gnomad FIN
AF:
0.550
Gnomad MID
AF:
0.339
Gnomad NFE
AF:
0.456
Gnomad OTH
AF:
0.381
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.342
AC:
51986
AN:
152054
Hom.:
11141
Cov.:
32
AF XY:
0.342
AC XY:
25438
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.0836
AC:
3472
AN:
41522
American (AMR)
AF:
0.415
AC:
6339
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.403
AC:
1398
AN:
3466
East Asian (EAS)
AF:
0.305
AC:
1573
AN:
5164
South Asian (SAS)
AF:
0.201
AC:
968
AN:
4820
European-Finnish (FIN)
AF:
0.550
AC:
5793
AN:
10526
Middle Eastern (MID)
AF:
0.350
AC:
103
AN:
294
European-Non Finnish (NFE)
AF:
0.456
AC:
31021
AN:
67976
Other (OTH)
AF:
0.379
AC:
800
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1527
3054
4581
6108
7635
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
486
972
1458
1944
2430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.428
Hom.:
30650
Bravo
AF:
0.326
Asia WGS
AF:
0.250
AC:
871
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Jul 31, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 73% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 68. Only high quality variants are reported.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
4.6
DANN
Benign
0.73
PhyloP100
0.75
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4866929; hg19: chr5-45266589; API